Nova (NVMI) SEC Filings & 10K Form

$178.29
+4.07 (+2.34%)
(As of 05/3/2024 ET)

Recent Nova SEC Filings

DateFilerForm TypeView
04/18/2024
7:00 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
6:00 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
3:16 PM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2024
5:59 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
7:32 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
6:00 AM
Nova (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/20/2024
5:44 AM
Nova (Subject)
Wolfing Shay (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
5:35 AM
David Dror (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
6:30 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2024
6:30 AM
Nova (Subject)
Simon Zehava (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
4:23 PM
Nova (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
02/09/2024
8:28 AM
FMR LLC (Filed by)
Nova (Subject)
Form SC 13G/A
01/31/2024
5:04 AM
Migdal Insurance & Financial Holdings Ltd. (Filed by)
Nova (Subject)
Form SC 13G
01/30/2024
7:06 AM
Harel Insurance Investments & Financial Services Ltd. (Filed by)
Nova (Subject)
Form SC 13G/A
01/19/2024
5:13 AM
Nova (Subject)
Simon Zehava (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2024
6:01 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2024
7:00 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/03/2024
6:00 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/14/2023
6:58 AM
Aboody Efraim (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
5:26 AM
Nova (Subject)
Wilson Adrian Stuart (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/09/2023
6:30 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2023
7:00 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2023
6:12 AM
Nova (Subject)
Wilson Adrian Stuart (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2023
5:57 AM
COHEN AVI (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
5:11 AM
Nova (Subject)
Waisman Gabriel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
7:41 AM
Nova (Subject)
Wilson Adrian Stuart (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
5:18 AM
David Dror (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2023
6:20 AM
Cohen Raanan (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2023
7:00 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2023
6:00 AM
Cohen Raanan (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
7:00 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/03/2023
6:30 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2023
7:01 AM
Nova (Subject)
Simon Zehava (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2023
7:01 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2023
5:52 AM
Brunstein Michael (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2023
6:07 AM
Eyal Gruber Dafna (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2023
5:28 AM
Nova (Subject)
Oppenhaim Eitan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
6:26 AM
Brunstein Michael (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
5:47 AM
Nova (Subject)
Simon Zehava (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2023
5:27 AM
Brunstein Michael (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2023
6:47 AM
Brunstein Michael (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Investors Alert: The Next Big Thing in Weight Loss (Ad)

UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year.

Get the name of the stock here >>>
05/31/2023
6:41 AM
Eyal Gruber Dafna (Reporting)
Nova (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2023
6:24 AM
Nova (Subject)
Waisman Gabriel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2023
7:01 AM
Nova (Filer)
Form SD
Specialized Disclosure Report  
05/30/2023
6:06 AM
Nova (Subject)
Oppenhaim Eitan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2023
7:00 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2023
6:00 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2023
6:30 AM
Nova (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NVMI) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners